Aetna has released the details of its Medicare Advantage plans for 2026, which focus on preventative care and drug cost ...

A remarkably low translation rate of 0.14% of colorectal cancer (CRC) biomarkers have been approved for patient care. The ...

SCAN Health Plan will expand its 2026 Medicare Advantage benefits with $0 copays and higher dental, vision and allowance ...

Rhapsido is the first and only Bruton’s tyrosine kinase (BTK) inhibitor approved for chronic spontaneous urticaria (CSU).

Most of the exposure to misinformation about cancer treatment occurs in conversations with family and friends and on social ...

Panelists discuss how bimekizumab treatment preserves workforce participation and productivity while maintaining a favorable safety profile. Oral candidiasis is the main distinguishing side effect ...

Pfizer only offered to discount six products through the Most Favored Nation program, and healthcare policy experts suggest the real-world impact remains uncertain.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Novartis said that it is exploring an additional direct-to-employer model to increase access and affordability for ...

Enrollment in Medicare Advantage Special Needs Plans (SNPs) has grown steadily since becoming permanent in 2018, now ...

Panelists discuss how maintaining patients on effective single therapies for Crohn’s disease is preferable to switching ...

In a recent trial, verapamil showed a trend toward preserving insulin-producing beta cells in patients with Type 1 diabetes but failed to achieve statistical significance.